Drugs Whose Patents Expire in 2025 ?

Generic drugs are copies of original branded drugs, containing the same active ingredients, dosage, and form. They are produced after the patent of the original drug expires. SEN Pharma has compiled a list of some drug patents that are set to expire in 2025.

Benefits of Generic Drugs

Generic drugs are identical to their branded counterparts in terms of active ingredients, dosage, and form. They are introduced to the market once the patent of the original drug expires.

Why are generic drugs so popular? Let’s review some of the prominent benefits of these drugs:

Lower Cost: The most significant advantage of generic drugs is their affordability. Since generic drug manufacturers do not need to invest in research, development, and advertising as the original drug makers do, the production cost is considerably lower. This results in significant savings for patients in terms of treatment costs.
Guaranteed Quality: Although they are less expensive, the quality of generic drugs is not inferior to that of branded drugs. Generic drugs undergo rigorous testing by regulatory agencies to ensure safety and efficacy. In the U.S. and Europe, all generic drugs must undergo bioequivalence studies to be approved for sale. In Vietnam, 26 active ingredients are required to undergo bioequivalence testing.
More Choices: The availability of generic drugs increases competition in the pharmaceutical market, offering more choices for patients. It is easy to find multiple generic versions of the same active ingredient, allowing individuals to select the product that suits their needs and financial situation.
Reducing the Burden on Healthcare Systems: The widespread use of generic drugs helps reduce costs for healthcare facilities and insurance providers. This contributes to easing the burden on government budgets and allows healthcare systems to serve more patients.

Which Drugs Will Have Their Patents Expire in năm 2025?

Several commonly used drugs for treating conditions such as diabetes, hypertension, and cardiovascular diseases are expected to have their patents expire in 2025. SEN Pharma has compiled a detailed list of these drugs.

For pharmaceutical companies, preparing for the expiration of patents is essential, and it should begin at least 3 to 5 years in advance. The development process for generic drugs, although faster than for original drugs (due to the reduction of some phases), still requires basic research to ensure he quality (safety and efficacy) of the drug in treatment. Let’s look forward to seeing how companies will introduce new generic drugs to the market.